您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 论文 • 上一篇    下一篇

Her-2/neu,Syndecan-1在胃癌中的表达及意义

王潍博1,刘丰基2,崔言刚1   

  1. 1. 山东省立医院化疗科, 山东 济南 250021; 2. 潍坊市人民医院保健科, 山东 潍坊 261041
  • 收稿日期:2005-09-14 修回日期:1900-01-01 出版日期:2006-09-24 发布日期:2006-09-24
  • 通讯作者: 王潍博

WANG Wei-bo,LIU Ji-feng,CUI Yan-gang   

  • Received:2005-09-14 Revised:1900-01-01 Online:2006-09-24 Published:2006-09-24
  • Contact: WANG Wei-bo

摘要: 目的:检测胃癌组织中Her2/neu,Syndecan1表达情况,探讨二者在胃癌发生发展及侵袭、转移中的作用。方法:应用免疫组化SP法检测112例胃癌组织及40例正常胃粘膜中Her2/neu,Syndecan1表达。结果:① 112例胃癌组织和40例正常胃粘膜中Her2/neu阳性表达率分别为20.5%和5%,Syndecan1阳性表达率分别为46.4%和100.0%。胃癌组织Her2/neu阳性表达率显著高于正常胃粘膜阳性表达率(χ2=5.17,P<0.05),正常胃粘膜Syndecan1阳性表达率显著高于胃癌组织(χ2=20.80,P<0.01);② 胃癌组织 Her2/neu的表达与胃癌分化程度(χ2=4.82,P<0.05),TNM分期(χ2=5.37,P<0.05)、淋巴结转移多少(χ2=6.42,P<0.05)及浆膜浸润(χ2=7.30,P<0.01)均显著相关; ③ 胃癌组织Syndecan1的表达与胃癌分化程度、淋巴结转移呈负相关(χ2=11.83,P<0.01和χ2=13.74,P<0.01);④ 胃癌组织中Her2/neu阳性表达与Syndecan1的阴性表达显著相关(χ2=14.25,P<0.01)。结论:① Her2/neu高表达显示胃癌恶性程度高、分期晚、预后不良;② Syndecan1属保护性因素,在恶性程度高、分期晚的患者中表达降低;③ Her2/neu阳性表达的胃癌组织中Syndecan1的表达降低。

Abstract: To study the effect of Her2/neu and Syndecan1 in gastric carcinoma. Methods: The expressions of Her2/neu and Syndecan1 were measured by using immunohistochemistry method in 112 patients with gastric cancer and 40 healthy controls. Results: ① Her2/neu was expressed in 20.5 % of the gastric cancer tissue and 5.0% of the healthy gastric mucosa (χ2=5.17, P < 0.05), and Syndecan1 was expressed in 46.4% of the gastric cancer tissue and 100% of the healthy mucosa (χ2=20.80, P< 0.01); ② the expression of Her2/neu was significantly correlated with the differentiation, lymph node metastasis and clinical stage (P<0.05) and depth of invasion (P<0.01); ③ the expression of Syndecan1 was significantly correlated with the differentiation and the lymph node metastasis (P< 0.01). Conclusion: ① The expression of Her2/neu is significantly correlated with the clinicopathological factors (P<0.05) which suggests that Her2/neu is a risk factor for gastric cancer; ② the expression of Syndecan1 is significantly correlated with the differentiation and the lymph node metastasis, which suggests that Syndecan1 is a protective factor for gastric cancer;  ③ the expression of Her2/neu in gastric cancer tissue is significantly correlated with that of Syndecan1.

Key words: Gastric neoplasms, Her2/neu, Syndecan1, Immunohistochemistry, Clinical grade, Tumor metastasis, Prognosis

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!